Sunnyvale, CA, United States of America

Andrew Kennedy

This inventor holds 4 USPTO granted patents. Top assignees: Agilent Technologies, Inc., Leland Stanford Junior University. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Kennedy. Retrieved from https://idiyas.com/inventor/andrew-kennedy-tolh9hl7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Kennedy

Introduction

Andrew Kennedy is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of genome editing, particularly through his work with CRISPR technology. With a total of 4 patents, Kennedy's innovations have the potential to enhance the specificity and efficiency of genetic modifications.

Latest Patents

Kennedy's latest patents include groundbreaking methods and compositions for blocking off-target nucleic acids from cleavage by CRISPR proteins. This invention focuses on reagents and methods that improve the precision of genome editing by CRISPR-associated (Cas) protein systems. Another significant patent involves compounds and methods for CRISPR/Cas-based genome editing by homologous recombination. This invention introduces guide RNAs with modified adaptor segments that are resistant to degradation by RNaseH, facilitating more effective genetic alterations.

Career Highlights

Throughout his career, Andrew Kennedy has worked with prominent organizations such as Agilent Technologies, Inc. and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate with leading experts in the field of genetic research.

Collaborations

Some of his notable coworkers include Chong Wing Yung and Daniel E. Ryan. Their collaborative efforts have contributed to the advancement of CRISPR technology and its applications in genome editing.

Conclusion

Andrew Kennedy's work in the realm of genome editing exemplifies the innovative spirit of modern science. His patents and collaborations continue to pave the way for advancements in genetic research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…